Portugal is entitled to receive 6.9 million doses, according to European Union
Share
LIVE, FREE and EXCLUSIVE

An office site of biopharmaceutical company CureVac in Frankfurt am Main. Source: EPA
Published
By Francisco Sena Santos
Source: SBS
Share this with family and friends


